A series of molecules such as hypoxia induced HIF-1α, TGF-β, and NOTCH1 have been reported to promote CSC transdifferentiate to endothelial cells or pericytes in glioblastoma, breast cancer, and renal carcinomas. This evidence concerns the gene HIF1A and breast carcinoma.